EP3692041A1 — Processes for the preparation of cis-4 [2-{(3s.4r)-3-fluorooxan-4-yl]amino)-8-(2,4,6-trichloroanilino)-9h-purin-9-yl]-1-methylcyclohexane-1-carboxamide
Assigned to Celgene Corp · Expires 2020-08-12 · 6y expired
What this patent protects
The present invention relates to processes for the preparation of cis-4- [2 - {[(3S, 4R) -3-fluorooxan-4-yl] amino} -8- (2,4,6-trichloroanilino) -9H-purine 1-methylcyclohexane-1-carboxamide, alternatively designated (1-4S) -4- (2 - (((3S, 4R) -3-fluorotetrahydro-2H-pyran-4-yl) am…
USPTO Abstract
The present invention relates to processes for the preparation of cis-4- [2 - {[(3S, 4R) -3-fluorooxan-4-yl] amino} -8- (2,4,6-trichloroanilino) -9H-purine 1-methylcyclohexane-1-carboxamide, alternatively designated (1-4S) -4- (2 - (((3S, 4R) -3-fluorotetrahydro-2H-pyran-4-yl) amino) (1- (2,4,6-trichlorophenyl) amino) -9H-purin-9-yl) -1-methylcyclohexane-1-carboxamide, or a salt, solvate, hydrate or isotopologue thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.